ICCM
Icecure MedicalFNasdaq / Health Care Equipment & Services
Last Price
At close
2026-06-03
Current thesis
Positive clinical readouts and signed distribution agreements restore confidence; modest revenue growth and improved margins could re-rate the stock toward small-cap medtech peers.
Posture
Defensive
Lead driver
Value
What changed
Value remains the lead driver in the composite, 7D delta +20.0.
What can break
Clinical or regulatory setbacks for cryoablation devices
Momentum
21
Value
56
Sentiment
15
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $0.14 · Bull $0.22 · Bear $0.07
Data freshness
Prices
As of 2026-06-03
Fundamentals
As of 2026-06-02 • Vendor: Data Vendor v1
Scores
As of 2026-06-03 • Model: HYBRID_IC_RP
AI Memo
As of 2025-11-04 • Model: RankAlpha Sentiment AI
Investment thesisAs of 2026-06-03
Investment thesis
As of 2026-06-03
Supporting evidence
What
Grade F · Defensive
Confidence Medium · Net Neutral
Target $3.13
Why
Momentum21 · Δ7d -
Value56 · Δ7d +20.0
Sentiment15 · Δ7d -
So what
Weak posture (Net Neutral). Prioritize risk control and patience.
Lead driver: Value · See fundamentals
Momentum
21
34% active weight
Current posture
7d trendTrend unavailable
Trend unavailable
Δ7d
-
Δ21d
-
Value
56
32% active weight
Current posture
7d trendImproving
Δ7d
+20.0
Δ21d
+20.2
Sentiment
15
33% active weight
Current posture
7d trendTrend unavailable
Trend unavailable
Δ7d
-
Δ21d
-
Why this grade
Composite grade F. Momentum 21.3 / Value 56.4 / Sentiment 14.7
Fundamentals (TTM)As of 2026-06-02
Fundamentals (TTM)
As of 2026-06-02
Market Cap
$9.55M
Beta
2.28
Shares Out
68.96M
P/E (TTM) · Derived
-0.5
P/S (TTM)
15.07
P/FCF (TTM) · Derived
-0.60
Rev YoY
+28.4%
EPS YoY
+26.3%
Gross Margin
+35.1%
Op Margin
-517.7%
Net Debt
-$7.56M
Current Ratio
2.38
As of 2026-06-03 • Updated nightlySource: Internal modelMethodology